Voranigo Vorasidenib Tablets

Voranigo Vorasidenib Tablets

Therapeutic Class: ANTI NEOPLASTICS
Get Quote

Voranigo Vorasidenib Tablets is a first-in-class, once-daily oral inhibitor approved by the FDA (August 2024) to treat adults and pediatric patients (12+) with IDH1- or IDH2-mutant Grade 2 astrocytoma or oligodendroglioma.

Salt Composition: Vorasadenib (40mg)
Strength: Vorasadenib (40mg)
Pack Size: bottle of 30 Tablets
Uses: Brain tumor
Table Header
Salt Composition
Vorasadenib (40mg)
Strength
Vorasadenib (40mg)
Pack Size
bottle of 30 Tablets
Uses
Brain tumor
SKU Voranigo Vorasidenib Tablets Category Tag Brand:
DISCLAIMER
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India. Product is supplied for Tenders/ Emergency imports/ Unlicensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Product names, logos, brands and other trademarks featured or referred to are the property of their respective Trademark Holders. The information provided here is for Informational purposes only.

Product information is meant for


WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories